Home

DOMAIN PARTNERS V LP

CIK 1207785 · last filed 2012-03-27

DOMAIN PARTNERS V LP is a corporate insider who has filed 9 SEC Form 4 insider transactions across 3 companies since 2007. Across all open-market trades the lifetime net is +$5.9M, making them a net buyer over the disclosed history. The firm reports its address in Princeton, NJ.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

9

Lifetime Open-Market Net

$5.92M

Filer Profile

Reported Address
ONE PALMER SQUARE
PRINCETON, NJ 08542
Phone
(609) 683-5656
Related Filers
DP V ASSOCIATES LP — same reported address
DP VI Associates, L.P. — same reported address
Domain Partners VI, L.P. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Paratek Pharmaceuticals, Inc. (NOVC) Delisted 10%+ Owner 2,907,523 — — -$233.3K 2 2009-01-30
Volcano Corp (VOLC) Delisted 10%+ Owner 2,646,328 — — $0 3 2008-07-18
Orexigen Therapeutics, Inc. (OREX) Delisted 10%+ Owner 354,383 — — $6.15M 2 2007-11-29

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2012-03-27 — Sell (S) −1,656,581 -$8.55M
2010-12-20 — Mixed +5,262,583 $7.61M
2009-01-30 Paratek Pharmaceuticals, Inc. (NOVC) Delisted Sell (S) −244,300 -$233.3K EDGAR
2008-07-18 Volcano Corp (VOLC) Delisted Other (J) −662,711 $0 EDGAR
2008-04-10 Volcano Corp (VOLC) Delisted Other (J) −576,270 $0 EDGAR
2007-11-29 Orexigen Therapeutics, Inc. (OREX) Delisted Other (J) −900,000 $0 EDGAR
2007-06-05 Paratek Pharmaceuticals, Inc. (NOVC) Delisted Other (J) −1,000,000 $0 EDGAR
2007-05-11 Volcano Corp (VOLC) Delisted Other (J) −864,406 $0 EDGAR
2007-05-01 Orexigen Therapeutics, Inc. (OREX) Delisted Mixed +4,189,832 $6.15M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.